FSLY insider files Form 144 to sell 14,000 RSU-derived shares on NYSE
Rhea-AI Filing Summary
Fastly, Inc. (FSLY) Form 144 summary
This notice reports a proposed sale of 14,000 shares of Fastly common stock, acquired as restricted stock units on 08/15/2023. The sale is to be effected through Morgan Stanley Smith Barney LLC on the NYSE with an approximate aggregate market value of $108,220.00. The filing indicates 14,000 shares to be sold against a reported 147,400,000 shares outstanding and lists an approximate sale date of 09/15/2025. No securities were reported sold in the past three months, and no purchase consideration other than issuance by the issuer is reported.
Positive
- Transparency: The filing provides clear details on the number of shares, acquisition date, acquisition type (RSUs), broker, and aggregate market value.
- No recent sales: The filer reports "Nothing to Report" for securities sold in the past three months, indicating no recent dispositions to aggregate with this sale.
Negative
- Limited information: The form does not disclose the identity of the person for whose account the securities are to be sold or specify whether a Rule 10b5-1 plan exists.
- Timing uncertainty: The approximate sale date is listed as a single date (09/15/2025) without details on execution window or method beyond broker name.
Insights
TL;DR Proposed sale of 14,000 RSU-derived shares via Morgan Stanley; small relative to total outstanding shares.
The filing documents a planned sale of 14,000 common shares derived from restricted stock units granted on 08/15/2023 and shows an aggregate market value of $108,220.00. The sale is to be executed through Morgan Stanley Smith Barney LLC on the NYSE around 09/15/2025. With 147.4 million shares reported outstanding, the volume is immaterial on a percentage basis and the filing notes no other sales in the prior three months. This is a routine insider disposition notice under Rule 144; no additional financial or operational information about Fastly is provided in the form.
TL;DR Routine Rule 144 notice for RSU-derived shares; contains standard seller representations.
The filer represents they are unaware of undisclosed material adverse information and the form includes standard attestations related to Rule 10b5-1 awareness. The filing lists acquisition as issuer-granted RSUs with payment/consideration noted as N/A. There are no disclosed trading plans, plan adoption dates, or recent sales to aggregate, and no governance actions or disclosures beyond the sale notice.